<?xml version="1.0" encoding="UTF-8"?><!--Transformation version 1.3--><legislativeDoc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.lexisnexis.com/xmlschemas/content/public/legislativedoc/1/" schemaVersion="1.0"><legislativeDocHead><citations><citeForThisResource citeDefinition="#7159#349#000054#     1#         3446#">Va. Code Ann. ยง 54.1-3446</citeForThisResource></citations><legislativeBodyInfo><jurisdiction><jurisSystem normalizedLongName="Virginia" normalizedShortName="VA"/></jurisdiction></legislativeBodyInfo></legislativeDocHead><legislativeDocBody><statute><level levelType="section"><anchor id="_54.1-3446"/><heading><desig>ยง 54.1-3446.</desig><title>Schedule I</title></heading><level levelType="paragraph"><bodyText><p>The controlled substances listed in this section are included in Schedule I:</p></bodyText><level levelType="paragraph"><anchor id="_1"/><heading><desig>1.</desig></heading><bodyText><p> Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>Acetylmethadol;</p><p><pre/>Allylprodine;</p><p><pre/>Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);</p><p><pre/>Alphameprodine;</p><p><pre/>Alphamethadol;</p><p><pre/>Benzethidine;</p><p><pre/>Betacetylmethadol;</p><p><pre/>Betameprodine;</p><p><pre/>Betamethadol;</p><p><pre/>Betaprodine;</p><p><pre/>Clonitazene;</p><p><pre/>Dextromoramide;</p><p><pre/>Diampromide;</p><p><pre/>Diethylthiambutene;</p><p><pre/>Difenoxin;</p><p><pre/>Dimenoxadol;</p><p><pre/>Dimepheptanol;</p><p><pre/>Dimethylthiambutene;</p><p><pre/>Dioxaphetylbutyrate;</p><p><pre/>Dipipanone;</p><p><pre/>Ethylmethylthiambutene;</p><p><pre/>Etonitazene;</p><p><pre/>Etoxeridine;</p><p><pre/>Furethidine;</p><p><pre/>Hydroxypethidine;</p><p><pre/>Ketobemidone;</p><p><pre/>Levomoramide;</p><p><pre/>Levophenacylmorphan;</p><p><pre/>Morpheridine;</p><p><pre/>Noracymethadol;</p><p><pre/>Norlevorphanol;</p><p><pre/>Normethadone;</p><p><pre/>Norpipanone;</p><p><pre/>Phenadoxone;</p><p><pre/>Phenampromide;</p><p><pre/>Phenomorphan;</p><p><pre/>Phenoperidine;</p><p><pre/>Piritramide;</p><p><pre/>Proheptazine;</p><p><pre/>Properidine;</p><p><pre/>Propiram;</p><p><pre/>Racemoramide;</p><p><pre/>Tilidine;</p><p><pre/>Trimeperidine.</p></bodyText></level></level><level levelType="paragraph"><anchor id="_2"/><heading><desig>2.</desig></heading><bodyText><p> Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>Acetorphine;</p><p><pre/>Acetyldihydrocodeine;</p><p><pre/>Benzylmorphine;</p><p><pre/>Codeine methylbromide;</p><p><pre/>Codeine-N-Oxide;</p><p><pre/>Cyprenorphine;</p><p><pre/>Desomorphine;</p><p><pre/>Dihydromorphine;</p><p><pre/>Drotebanol;</p><p><pre/>Etorphine;</p><p><pre/>Heroin;</p><p><pre/>Hydromorphinol;</p><p><pre/>Methyldesorphine;</p><p><pre/>Methyldihydromorphine;</p><p><pre/>Morphine methylbromide;</p><p><pre/>Morphine methylsulfonate;</p><p><pre/>Morphine-N-Oxide;</p><p><pre/>Myrophine;</p><p><pre/>Nicocodeine;</p><p><pre/>Nicomorphine;</p><p><pre/>Normorphine;</p><p><pre/>Pholcodine;</p><p><pre/>Thebacon.</p></bodyText></level></level><level levelType="paragraph"><anchor id="_3"/><heading><desig>3.</desig></heading><bodyText><p> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subdivision only, the term "isomer" includes the optical, position, and geometric isomers):</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>Alpha-ethyltryptamine (some trade or other names: Monase;a-ethyl-1H-indole-3-ethanamine; 3-2-aminobutyl] indole; a-ET; AET);</p><p><pre/>4-Bromo-2,5-dimethoxyphenethylamine (some trade or other names: 2-4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;alpha-desmethyl DOB; 2C-B; Nexus);</p><p><pre/>4-Bromo-2,5-dimethoxyphenethylamine (some trade or other names: 2-4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;alpha-desmethyl DOB; 2C-B; Nexus);</p><p><pre/>3,4-methylenedioxy amphetamine;</p><p><pre/>5-methoxy-3,4-methylenedioxy amphetamine;</p><p><pre/>3,4,5-trimethoxy amphetamine;</p><p><pre/>Alpha-methyltryptamine (other name: AMT);</p><p><pre/>Bufotenine;</p><p><pre/>Diethyltryptamine;</p><p><pre/>Dimethyltryptamine;</p><p><pre/>4-methyl-2,5-dimethoxyamphetamine;</p><p><pre/>2,5-dimethoxy-4-ethylamphetamine (DOET);</p><p><pre/>2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);</p><p><pre/>Ibogaine;</p><p><pre/>5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT);</p><p><pre/>Lysergic acid diethylamide;</p><p><pre/>Mescaline;</p><p><pre/>Parahexyl (some trade or other names: 3-Hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo -b,d] pyran; Synhexyl);</p><p><pre/>Peyote;</p><p><pre/>N-ethyl-3-piperidyl benzilate;</p><p><pre/>N-methyl-3-piperidyl benzilate;</p><p><pre/>Psilocybin;</p><p><pre/>Psilocyn;</p><p><pre/>Salvinorin A;</p><p><pre/>Tetrahydrocannabinols, except as present in marijuana and dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the U.S. Food and Drug Administration;</p><p><pre/>Hashish oil (some trade or other names: hash oil; liquid marijuana; liquid hashish);</p><p><pre/>2,5-dimethoxyamphetamine (some trade or other names: 2,5-dimethoxy-a-methylphenethylamine; 2,5-DMA);</p><p><pre/>3,4-methylenedioxymethamphetamine (MDMA), its optical, positional and geometric isomers, salts and salts of isomers;</p><p><pre/>3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA);</p><p><pre/>N-hydroxy-3,4-methylenedioxyamphetamine (some other names: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);</p><p><pre/>4-bromo-2,5-dimethoxyamphetamine (some trade or other names: 4-bromo-2,5-dimethoxy-a-methylphenethylamine; 4-bromo-2,5-DMA);</p><p><pre/>4-methoxyamphetamine (some trade or other names: 4-methoxy-a-methylphenethylamine; paramethoxyamphetamine; PMA);</p><p><pre/>Ethylamine analog of phencyclidine (some other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE);</p><p><pre/>Pyrrolidine analog of phencyclidine (some other names: 1-(1-phenylcyclohexyl) -pyrrolidine, PCPy, PHP);</p><p><pre/>Thiophene analog of phencyclidine (some other names: 1-1-(2-thienyl) -cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP);</p><p><pre/>1-1-(2-thienyl)cyclohexyl]pyrrolidine (other name: TCPy);</p><p><pre/>3,4-methylenedioxypyrovalerone (other name: MDPV);</p><p><pre/>4-methylmethcathinone (other names: mephedrone, 4-MMC);</p><p><pre/>3,4-methylenedioxymethcathinone (other name: methylone);</p><p><pre/>Naphthylpyrovalerone (other name: naphyrone);</p><p><pre/>4-fluoromethcathinone (other name: flephedrone, 4-FMC);</p><p><pre/>4-methoxymethcathinone (other names: methedrone; bk-PMMA);</p><p><pre/>Ethcathinone (other name: N-ethylcathinone);</p><p><pre/>3,4-methylenedioxyethcathinone (other name: ethylone);</p><p><pre/>Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (other name: butylone);</p><p><pre/>N,N-dimethylcathinone (other name: metamfepramone);</p><p><pre/>Alpha-pyrrolidinopropiophenone (other name: alpha-PPP);</p><p><pre/>4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP);</p><p><pre/>3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP);</p><p><pre/>Alpha-pyrrolidinovalerophenone (other name: alpha-PVP);</p><p><pre/>6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine (other name: MDAI);</p><p><pre/>3-fluoromethcathinone (other name: 3-FMC);</p><p><pre/>4-Ethyl-2,5-dimethoxyphenethylamine (other name: 2C-E);</p><p><pre/>4-Iodo-2,5-dimethoxyphenethylamine (other name: 2C-I);</p><p><pre/>4-Methylethcathinone (other name: 4-MEC);</p><p><pre/>4-Ethylmethcathinone (other name: 4-EMC);</p><p><pre/>N,N-diallyl-5-methoxytryptamine (other name: 5-MeO-DALT);</p><p><pre/>Beta-keto-methylbenzodioxolylpentanamine (other name: Pentylone, bk-MBDP);</p><p><pre/>Alpha-methylamino-butyrophenone (other name: Buphedrone);</p><p><pre/>Alpha-methylamino-valerophenone (other name: Pentedrone);</p><p><pre/>3,4-Dimethylmethcathinone (other name: 3.4-DMMC);</p><p><pre/>4-methyl-alpha-pyrrolidinopropiophenone (other name: MPPP);</p><p><pre/>4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names: 25-I, 25I-NBOMe);</p><p><pre/>Methoxetamine (other names: MXE, 3-MeO-2-Oxo-PCE);</p><p><pre/>4-Fluoromethamphetamine (other name: 4-FMA);</p><p><pre/>4-Fluoroamphetamine (other name: 4-FA);</p><p><pre/>2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (other name: 2C-D);</p><p><pre/>2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (other name: 2C-C);</p><p><pre/>2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (other name: 2C-T-2);</p><p><pre/>2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (other name: 2C-T-4);</p><p><pre/>2-(2,5-Dimethoxyphenyl)ethanamine (other name: 2C-H);</p><p><pre/>2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (other name: 2C-N);</p><p><pre/>2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (other name: 2C-P);</p><p><pre/>(2-aminopropyl)benzofuran (other name: APB);</p><p><pre/>(2-aminopropyl)-2,3-dihydrobenzofuran (other name: APDB);</p><p><pre/>4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names: 2C-C-NBOMe, 25C-NBOMe);</p><p><pre/>4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names: 2C-B-NBOMe, 25B-NBOMe);</p><p><pre/>Acetoxydimethyltryptamine (other names: AcO-Psilocin, AcO-DMT, Psilacetin);</p><p><pre/>Benocyclidine (other names: BCP, BTCP);</p><p><pre/>Alpha-pyrrolidinobutiophenone (other name: alpha-PBP);</p><p><pre/>3,4-methylenedioxy-N,N-dimethylcathinone (other names: Dimethylone, bk-MDDMA);</p><p><pre/>4-bromomethcathinone (other name: 4-BMC);</p><p><pre/>4-chloromethcathinone (other name: 4-CMC);</p><p><pre/>4-Iodo-2,5-dimethoxy-N-[(2-hydroxyphenyl)methyl]-benzeneethanamine (other name: 25I-NBOH);</p><p><pre/>lpha-Pyrrolidinohexiophenone (other name: alpha-PHP);</p><p><pre/>Alpha-Pyrrolidinoheptiophenone (other name: PV8).</p></bodyText></level></level><level levelType="paragraph"><anchor id="_4"/><heading><desig>4.</desig></heading><bodyText><p> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>Gamma hydroxybutyric acid (some other names include GHB; gamma hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);</p><p><pre/>Mecloqualone;</p><p><pre/>Methaqualone.</p><p><pre/>Etizolam.</p></bodyText></level></level><level levelType="paragraph"><anchor id="_5"/><heading><desig>5.</desig></heading><bodyText><p> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>Aminorex (some trade or other names; aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4, 5-dihydro-5-phenyl-2-oxazolamine);</p><p><pre/>N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine);</p><p><pre/>Fenethylline;</p><p><pre/>Ethylamphetamine;</p><p><pre/>Cathinone (some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, norephedrone), and any plant material from which Cathinone may be derived;</p><p><pre/>Methcathinone (some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)-propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR 1432);</p><p><pre/>Cis-4-methylaminorex (other name: cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);</p><p><pre/>N,N-dimethylamphetamine (other names: N,N-alpha-trimethyl-benzeneethanamine, N,N-alpha-trimethylphenethylamine).</p></bodyText></level></level><level levelType="paragraph"><anchor id="_6"/><heading><desig>6.</desig></heading><bodyText><p> Any material, compound, mixture or preparation containing any quantity of the following substances:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>N-3-methyl-1-(2-phenethyl)-4-piperidyl]-N-phenylpropanamide (other name: 3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers;</p><p><pre/>1-methyl-4-phenyl-4-propionoxypiperidine (other name: MPPP), its optical isomers, salts and salts of isomers;</p><p><pre/>1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (other name: PEPAP), its optical isomers, salts and salts of isomers;</p><p><pre/>N-1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide (other names: 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine), alpha-methylfentanyl);</p><p><pre/>N-1-(1-methyl-2-phenethyl)-4-piperidyl]-N-phenylacetamide (other name: acetyl-alpha-methylfentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>N-1-(1-methyl-2-2-thienyl)ethyl-4 piperidyl]-N-phenylpropanamide (other name: alpha-methylthiofentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>N-1-benzyl-4-piperidyl]N-phenylpropanamide (other name: benzylfentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>N-1-(2-hydroxy-2-phenyl) ethyl-4-piperidyl]-N-phenylpropanamide (other name: beta-hydroxyfentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>N-3-methyl-1-(2-hydroxy-2-phenethyl)4-piperidyl]-N-phenylpropanamide (other name: beta-hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers;</p><p><pre/>N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide (other name: 3-methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers;</p><p><pre/>N-1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (other name: thienylfentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>N-phenyl-N-1-(2-thienyl)ethyl-4-piperidinyl]-propanamide (other name: thiofentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>N-(4-fluorophenyl)-N-1-(2-phenethyl)-4-piperidinyl]-propanamide (other name: para-fluorofentanyl), its optical isomers, salts and salts of isomers;</p><p><pre/>Acetyl fentanyl (other name: desmethyl fentanyl).</p></bodyText></level></level><level levelType="paragraph"><anchor id="_7"/><heading><desig>7.</desig></heading><bodyText><p> Any substance that contains one or more cannabimimetic agents or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, and any preparation, mixture, or substance containing, or mixed or infused with, any detectable amount of one or more cannabimimetic agents.</p></bodyText><level levelType="paragraph"><anchor id="_7_a"/><heading><desig>a.</desig></heading><bodyText><p> "Cannabimimetic agents" includes any substance that is within any of the following structural classes:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent;</p><p><pre/>3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent;</p><p><pre/>3-(1-naphthoyl)pyrrole with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent;</p><p><pre/>1-(1-naphthylmethyl)indene with substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent;</p><p><pre/>3-phenylacetylindole or 3-benzoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent;</p><p><pre/>3-cyclopropoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the cyclopropyl ring to any extent;</p><p><pre/>3-adamantoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent;</p><p><pre/>N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent; and</p><p><pre/>N-(adamantyl)-indazole-3-carboxamide with substitution at a nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent.</p></bodyText></level></level><level levelType="paragraph"><anchor id="_7_b"/><heading><desig>b.</desig></heading><bodyText><p> The term "cannabimimetic agents" includes:</p></bodyText><level levelType="paragraph"><bodyText><p><pre/>5-(1,1-Dimethylheptyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497);</p><p><pre/>5-(1,1-Dimethylhexyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497 C6 homolog);</p><p><pre/>5-(1,1-Dimethyloctyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497 C8 homolog);</p><p><pre/>5-(1,1-Dimethylnonyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497 C9 homolog);</p><p><pre/>1-pentyl-3-(1-naphthoyl)indole (other names: JWH-018, AM-678);</p><p><pre/>1-butyl-3-(1-naphthoyl)indole (other name: JWH-073);</p><p><pre/>1-pentyl-3-(2-methoxyphenylacetyl)indole (other name: JWH-250);</p><p><pre/>1-hexyl-3-(naphthalen-1-oyl)indole (other name: JWH-019);</p><p><pre/>1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (other name: JWH-200);</p><p><pre/>(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-te trahydrobenzo[c]chromen-1-ol (other name: HU-210);</p><p><pre/>1-pentyl-3-(4-methoxy-1-naphthoyl)indole (other name: JWH-081);</p><p><pre/>1-pentyl-3-(4-methyl-1-naphthoyl)indole (other name: JWH-122);</p><p><pre/>1-pentyl-3-(2-chlorophenylacetyl)indole (other name: JWH-203);</p><p><pre/>1-pentyl-3-(4-ethyl-1-naphthoyl)indole (other name: JWH-210);</p><p><pre/>1-pentyl-3-(4-chloro-1-naphthoyl)indole (other name: JWH-398);</p><p><pre/>1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (other name: AM-694);</p><p><pre/>1-((N-methylpiperidin-2-yl)methyl)-3-(1-naphthoyl)indole (other name: AM-1220);</p><p><pre/>1-(5-fluoropentyl)-3-(1-naphthoyl)indole (other name: AM-2201);</p><p><pre/>1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole (other name: AM-2233);</p><p><pre/>Pravadoline (4-methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]methanone (other name: WIN 48,098);</p><p><pre/>1-pentyl-3-(4-methoxybenzoyl)indole (other names: RCS-4, SR-19);</p><p><pre/>1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole (other names: RCS-8, SR-18);</p><p><pre/>1-pentyl-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: UR-144);</p><p><pre/>1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: XLR-11);</p><p><pre/>N-adamantyl-1-fluoropentylindole-3-carboxamide (other name: STS-135);</p><p><pre/>N-adamantyl-1-pentylindazole-3-carboxamide (other name: AKB48);</p><p><pre/>1-pentyl-3-(1-adamantoyl)indole (other name: AB-001);</p><p><pre/>(8-quinolinyl)(1-pentylindol-3-yl)carboxylate (other name: PB-22);</p><p><pre/>(8-quinolinyl)(1-(5-fluoropentyl)indol-3-yl)carboxylate (other name: 5-fluoro-PB-22);</p><p><pre/>(8-quinolinyl)(1-cyclohexylmethyl-indol-3-yl)carboxylate (other name: BB-22);</p><p><pre/>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide (other name: AB-PINACA);</p><p><pre/>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide (other name: AB-FUBINACA);</p><p><pre/>1-(5-fluoropentyl)-3-(1-naphthoyl)indazole (other name: THJ-2201);</p><p><pre/>N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide (other name: ADB-PINACA);</p><p><pre/>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other name: AB-CHMINACA);</p><p><pre/>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)indazole-3-carboxamide (other name: 5-fluoro-AB-PINACA);</p><p><pre/>N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other names: ADB-CHMINACA, MAB-CHMINACA);</p><p><pre/>Methyl-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other name: 5-fluoro-AMB);</p><p><pre/>1-naphthalenyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (other name: NM-2201);</p><p><pre/>1-(4-fluorobenzyl)-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: FUB-144);</p><p><pre/>1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (other name MAM-2201).</p></bodyText></level></level></level></level><history><historyGroup groupType="history-citation"><historyItem><bodyText><p>1972, c. 798, ยง 54-524.84:4; 1973, c. 479; 1976, c. 614; 1977, c. 302; 1979, cc. 387, 435; 1982, c. 505; 1984, cc. 186, 192; 1986, c. 463; 1988, c. 765; <citation normalizedCite="1994 VA CH 763"><content><span normalizedCite="1994 Va. Ch. 763">1994, c. 763<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#1994#000763#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="1996 VA CH 408"><content><span normalizedCite="1996 Va. Ch. 408">1996, c. 408<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#1996#000408#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="1997 VA CH 594"><content><span normalizedCite="1997 Va. Ch. 594">1997, c. 594<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#1997#000594#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="1999 VA CH 722"><content><span normalizedCite="1999 Va. Ch. 722">1999, c. 722<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#1999#000722#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2000 VA CH 348"><content><span normalizedCite="2000 Va. Ch. 348">2000, c. 348<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2000#000348#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2005 VA CH 119"><content><span normalizedCite="2005 Va. Ch. 119">2005, c. 119<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2005#000119#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2008 VA CH 59"><content><span normalizedCite="2008 Va. Ch. 59">2008, c. 59<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2008#000059#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2011 VA CH 384"><content><span normalizedCite="2011 Va. Ch. 384">2011, cc. 384<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2011#000384#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="2011 VA CH 410"><content><span normalizedCite="2011 Va. Ch. 410">410<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2011#000410#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2012 VA CH 762"><content><span normalizedCite="2012 Va. Ch. 762">2012, cc. 762<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2012#000762#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="2012 VA CH 816"><content><span normalizedCite="2012 Va. Ch. 816">816<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2012#000816#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2013 VA CH 295"><content><span normalizedCite="2013 Va. Ch. 295">2013, cc. 295<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2013#000295#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="2013 VA CH 785"><content><span normalizedCite="2013 Va. Ch. 785">785<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2013#000785#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2014 VA CH 674"><content><span normalizedCite="2014 Va. Ch. 674">2014, cc. 674<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2014#000674#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="2014 VA CH 719"><content><span normalizedCite="2014 Va. Ch. 719">719<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2014#000719#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2015 VA CH 726"><content><span normalizedCite="2015 Va. Ch. 726">2015, cc. 726<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2015#000726#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="2015 VA CH 757"><content><span normalizedCite="2015 Va. Ch. 757">757<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2015#000757#"/></locatorKey></locator></span></content></citation>; <citation normalizedCite="2016 VA CH 103"><content><span normalizedCite="2016 Va. Ch. 103">2016, cc. 103<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2016#000103#"/></locatorKey></locator></span></content></citation>, <citation normalizedCite="2016 VA CH 112"><content><span normalizedCite="2016 Va. Ch. 112">112<locator><locatorKey><keyName name="citeReference"/><keyValue value="#1834#131#2016#000112#"/></locatorKey></locator></span></content></citation>.</p></bodyText></historyItem></historyGroup></history></level></statute></legislativeDocBody><metadata><dc:metadata xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:identifier identifierScheme="PGUID">urn:contentItem:5K0Y-PTB0-004G-K2CK-00000-00</dc:identifier><dc:source sourceScheme="productContentSetIdentifier">10816</dc:source><dc:date dateType="last-updated">2016-06-15</dc:date></dc:metadata><publicationInfo><publicationName>CODE OF VIRGINIA </publicationName><copyright>Copyright ยฉ 2016  by Matthew Bender &amp; Company, Inc. a member of the LexisNexis Group. All rights reserved</copyright></publicationInfo><hierarchy><hierarchyLevel levelType="title"><heading><desig>TITLE 54.1.</desig><title>PROFESSIONS AND OCCUPATIONS</title></heading><hierarchyLevel levelType="subtitle"><heading><desig>SUBTITLE III.</desig><title>PROFESSIONS AND OCCUPATIONS REGULATED BY BOARDS WITHIN THE DEPARTMENT OF HEALTH PROFESSIONS</title></heading><hierarchyLevel levelType="chapter"><heading><desig>CHAPTER 34.</desig><title>DRUG CONTROL ACT</title></heading><hierarchyLevel levelType="article"><heading><desig>ARTICLE 5.</desig><title>STANDARDS AND SCHEDULES</title></heading></hierarchyLevel></hierarchyLevel></hierarchyLevel></hierarchyLevel></hierarchy><classification classificationScheme="legal"><classificationItem><className>Criminal Law &amp; Procedure</className><classCode>Z3VpZD11cm46dG9waWM6NEU0RkE1OUQwNUQwNDgxODhEODZCMjkzOTg3NThBNzk7cGFyZW50Z3VpZD0</classCode><classificationItem><className>Elements</className><classCode>Z3VpZD11cm46dG9waWM6NTREMUQ2OUQzRTUyNDg4NkExQjkzRDg0NUNDNTVFMDA7cGFyZW50Z3VpZD11cm46dG9waWM6OUM2OEFEMjIyOTc3NDM3NTgwMjQyOUFGQjY0MjkzQkU</classCode></classificationItem><classificationItem><className>Opiates</className><classCode>Z3VpZD11cm46dG9waWM6MjJBN0E1NjZBN0Q0NDYzQkJBQTlBOTMyNzNBNzZERDE7cGFyZW50Z3VpZD11cm46dG9waWM6QzFGQ0JDRjQ1RTA3NEJFOEI3QkVEREEyRDlFNTVBRDg</classCode></classificationItem></classificationItem></classification><classificationGroup classificationScheme="indexing-terms"><classification classificationScheme="legal"><classificationItem><className>Business &amp; Corporate Compliance</className><classCode>Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI7cGFyZW50Z3VpZD0</classCode><classificationItem score="90"><className>Businesses &amp; Corporations</className><classCode>Z3VpZD11cm46dG9waWM6QjA4OEVGODBENzY4NDcxM0IyQzA1OTEwQzVDODRBOUE7cGFyZW50Z3VpZD11cm46dG9waWM6MUFEMUQ2QTA1OUZCNEE5RjkzNTA2RERFMUNEOTk1RTI</classCode></classificationItem></classificationItem></classification></classificationGroup></metadata></legislativeDoc>